Frankfurt - Delayed Quote EUR

Crinetics Pharmaceuticals, Inc. (6Z4.F)

Compare
38.60
+1.60
+(4.32%)
As of 8:10:16 AM GMT+1. Market Open.

Research Analysis

Revenue vs. Earnings

Revenue --
Earnings -76.83M
Q4'23
Q1'24
Q2'24
Q3'24
-60M
-40M
-20M
0
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 1081212
Avg. Estimate 700k12.5k1.57M6.41M
Low Estimate ----1M3M
High Estimate 5M100k6M19.89M
Year Ago Sales --640k4.01M1.57M
Sales Growth (year/est) 0.00%-98.05%-60.84%308.02%

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
6Z4.F --------
S&P 500 9.01%10.57%14.00%13.70%

Upgrades & Downgrades

Upgrade Jefferies: Hold to Buy 1/22/2025
Reiterates HC Wainwright & Co.: Buy to Buy 1/13/2025
Reiterates JMP Securities: Market Outperform to Market Outperform 12/16/2024
Maintains Citigroup: Buy to Buy 11/14/2024
Maintains HC Wainwright & Co.: Buy to Buy 11/13/2024
Reiterates JMP Securities: Market Outperform to Market Outperform 9/27/2024